The ANK1 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HT-29 human colorectal adenocarcinoma cell line, designed for robust functional studies of ankyrin-1 (ANK1) in epithelial biology. This heterogeneous pool of gene-disrupted cells offers a loss-of-function model free from clonal selection bias, enabling physiologically relevant investigations of ANK1-dependent phenotypes. The polyclonal format preserves a broad spectrum of genetic and phenotypic heterogeneity, making it particularly valuable for studying complex traits such as cell adhesion, migration, and signaling network dynamics.
The host cell line, HT-29, originates from a primary colorectal adenocarcinoma and retains key characteristics of intestinal epithelial cells, including the capacity to form polarized monolayers with functional tight junctions under appropriate culture conditions. Widely utilized in colorectal cancer research, epithelial barrier studies, and signal transduction assays, HT-29 cells respond to external stimuli such as TGF-??, EGF, and WNT ligands. Their moderate differentiation potential and well-characterized cytoskeletal architecture provide a relevant and reproducible platform for dissecting the molecular mechanisms by which ANK1 contributes to epithelial homeostasis and malignant transformation.
ANK1 encodes ankyrin-R, a scaffold protein that tethers integral membrane proteins??including anion exchanger band 3 (SLC4A1), CD44, and E-cadherin (CDH1)??to the spectrin-actin cytoskeleton. By directly interacting with spectrin ??/?? (SPTA1/SPTB) and ??-catenin (CTNNB1), ANK1 stabilizes membrane domains and maintains epithelial polarity. Its activity is regulated by upstream cues such as TGF-??, EGF, WNT ligands, and RhoA, and it in turn spatially organizes actin (ACTB) networks. CRISPR/Cas9-mediated disruption of ANK1 dissociates the spectrin?Cactin meshwork from the plasma membrane, impairing the structural coordination between adhesion complexes and the cytoskeleton and thereby altering Rho GTPase and WNT/??-catenin pathway signaling.
In the HT-29 colorectal cancer context, loss of ANK1 compromises membrane-cytoskeleton linkage, leading to defective cell?Cmatrix and cell?Ccell adhesion, disorganized actin architecture, and diminished epithelial barrier function. This knockout model reveals ANK1??s role in modulating malignant phenotypes, including aberrant migration, invasion, and WNT/??-catenin pathway dysregulation. Because ANK1 scaffolds E-cadherin and ??-catenin at adherens junctions, its depletion may disrupt junctional dynamics and promote metastatic behavior. Additionally, the model serves as a valuable tool for studying cytoskeletal defects associated with hereditary spherocytosis, extending its applicability beyond colorectal cancer to broader cytoskeletal dysregulation disorders.
This polyclonal ANK1 knockout cell pool is well suited for a wide range of applications, from mechanistic dissection of membrane-cytoskeleton interactions to quantitative assays of tumor cell behavior. Researchers can employ immunofluorescence microscopy and co-immunoprecipitation to examine spectrin, actin, and adhesion protein assembly, while high-content cytoskeletal analysis and wound healing migration assays quantify collective cell movement. Transepithelial electrical resistance (TEER) measurements assess barrier integrity, and transwell invasion assays model metastatic potential. Drug discovery efforts targeting cytoskeletal nodes are supported by actin polymerization assays and screening for phenotypic reversion. For further information or technical support, please contact Ascent Research.
